PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively. PF-00835231 is the active compound of the first anti-3CLpro regimen in clinical trials.
Molecular Weight:
472.53
Purity:
97.83%
CAS Number:
[870153-29-0]
Formula:
C24H32N4O6
Target:
SARS-CoV
T9458
* VAT and and shipping costs not included. Errors and price changes excepted